{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T17:16:08Z","timestamp":1789578968778,"version":"build-2803163510"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T00:00:00Z","timestamp":1764633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T00:00:00Z","timestamp":1764633600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"DOI":"10.1186\/s12889-025-25491-1","type":"journal-article","created":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T14:51:10Z","timestamp":1764687070000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Optimizing tuberculosis infection screening strategies for people living with HIV in Thailand: a cost-effectiveness analysis"],"prefix":"10.1186","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-4159-0026","authenticated-orcid":false,"given":"Nuntana","family":"Chumpa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pirapon June","family":"Ohata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gompol","family":"Suwanpimolkul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,2]]},"reference":[{"key":"25491_CR1","unstructured":"World Health Organization. Global tuberculosis report 2023. https:\/\/www.who.int\/teams\/global-tuberculosis-programme\/tb-reports\/global-tuberculosis-report-2023. Accessed 5 Oct 2024."},{"key":"25491_CR2","doi-asserted-by":"publisher","first-page":"S58","DOI":"10.1016\/j.ijid.2019.02.035","volume":"80S","author":"M Rao","year":"2019","unstructured":"Rao M, Ippolito G, Mfinanga S, Ntoumi F, Yeboah-Manu D, Vilaplana C, Zumla A, Maeurer M, Latent TB. Infection (LTBI) - Mycobacterium tuberculosis pathogenesis and the dynamics of the granuloma battleground. Int J Infect Dis. 2019;80S:S58\u201361.","journal-title":"Int J Infect Dis"},{"key":"25491_CR3","first-page":"436","volume":"1","author":"GB Migliori","year":"2021","unstructured":"Migliori GB. M Raviglione 2021 Essential tuberculosis. Essent Tuberc 1 436.","journal-title":"Essent Tuberc"},{"issue":"3","key":"25491_CR4","doi-asserted-by":"publisher","DOI":"10.1183\/20734735.0079-2021","volume":"17","author":"GB Migliori","year":"2021","unstructured":"Migliori GB, Ong CWM, Petrone L, D\u2019Ambrosio L, Centis R, Goletti D. The definition of tuberculosis infection based on the spectrum of tuberculosis disease. Breathe (Sheff). 2021;17(3):210079.","journal-title":"Breathe (Sheff)"},{"issue":"2","key":"25491_CR5","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1097\/QAD.0000000000003747","volume":"38","author":"D van Geuns","year":"2024","unstructured":"van Geuns D, Arts RJW, de Vries G, Wit F, Degtyareva SY, Brown J, Pareek M, Lipman M, van Crevel R. Screening for tuberculosis infection and effectiveness of preventive treatment among people with HIV in low-incidence settings. AIDS. 2024;38(2):193\u2013205.","journal-title":"AIDS"},{"key":"25491_CR6","doi-asserted-by":"crossref","unstructured":"Migliori GB, Dowdy D, Denholm JT, D\u2019Ambrosio L, Centis R. The path to tuberculosis elimination: a renewed vision. Eur Respir J 2023;61(6):2300499.","DOI":"10.1183\/13993003.00499-2023"},{"issue":"3","key":"25491_CR7","doi-asserted-by":"publisher","first-page":"190","DOI":"10.5588\/ijtld.21.0753","volume":"26","author":"GB Migliori","year":"2022","unstructured":"Migliori GB, Wu SJ, Matteelli A, Zenner D, Goletti D, Ahmedov S, et al. Clinical standards for the diagnosis, treatment and prevention of TB infection. Int J Tuberc Lung Dis. 2022;26(3):190\u2013205.","journal-title":"Int J Tuberc Lung Dis"},{"key":"25491_CR8","unstructured":"World Health Organization. WHO consolidated guidelines on tuberculosis. Module 1: Prevention. Infection prevention and control. 12 September 2022. https:\/\/www.who.int\/publications\/i\/item\/9789240055889. Accessed 5 Oct 2024."},{"issue":"3","key":"25491_CR9","doi-asserted-by":"publisher","first-page":"177","DOI":"10.7326\/0003-4819-149-3-200808050-00241","volume":"149","author":"M Pai","year":"2008","unstructured":"Pai M, Zwerling A, Menzies D. Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update. Ann Intern Med. 2008;149(3):177\u201384.","journal-title":"Ann Intern Med"},{"issue":"5","key":"25491_CR10","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.jinf.2019.08.018","volume":"79","author":"G Sotgiu","year":"2019","unstructured":"Sotgiu G, Saderi L, Petruccioli E, Aliberti S, Piana A, Petrone L, et al. Quantiferon TB gold plus for the diagnosis of tuberculosis: a systematic review and meta-analysis. J Infect. 2019;79(5):444\u201353.","journal-title":"J Infect"},{"key":"25491_CR11","doi-asserted-by":"crossref","unstructured":"Dumitrescu F, Pisoschi CG, Padureanu V, Stoian AC, Dragonu L, Giubelan L. The Role of QuantiFERON-TB Gold Plus in Mycobacterium Tuberculosis Detection in a Severe HIV Immunocompromised Patient-Case Report. Pathogens. 2021;10(11):1523.","DOI":"10.3390\/pathogens10111523"},{"issue":"1","key":"25491_CR12","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.diagmicrobio.2010.09.005","volume":"69","author":"M Santin","year":"2011","unstructured":"Santin M, Casas S, Saumoy M, Andreu A, Moure R, Alcaide F, Ferrer E, Podzamczer D. Detection of latent tuberculosis by the tuberculin skin test and a whole-blood interferon-gamma release assay, and the development of active tuberculosis in HIV-seropositive persons. Diagn Microbiol Infect Dis. 2011;69(1):59\u201365.","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"5","key":"25491_CR13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0005718","volume":"4","author":"B Syed Ahamed Kabeer","year":"2009","unstructured":"Syed Ahamed Kabeer B, Sikhamani R, Swaminathan S, Perumal V, Paramasivam P, Raja A. Role of interferon gamma release assay in active TB diagnosis among HIV infected individuals. PLoS One. 2009;4(5):e5718.","journal-title":"PLoS One"},{"key":"25491_CR14","unstructured":"World Health Organization. WHO consolidated guidelines on tuberculosis. Module 3: Diagnosis. 16 April 2025. https:\/\/iris.who.int\/bitstream\/handle\/10665\/381003\/9789240107984-eng.pdf?sequence=1. Accessed 28 June 2025."},{"issue":"1","key":"25491_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-29648-z","volume":"13","author":"E Barker","year":"2023","unstructured":"Barker E, Moss J, Holmes H, Bowe C, Suryaprakash V, Alagna R, et al. A cost-effectiveness evaluation of latent tuberculosis infection screening of a migrant population in Malaysia. Sci Rep. 2023;13(1):2390.","journal-title":"Sci Rep"},{"key":"25491_CR16","unstructured":"aidsdatahub.org. HIV\/AIDS Data Hub for the Asia Pacific. https:\/\/www.aidsdatahub.org\/. Accessed 16 Sept 2024."},{"key":"25491_CR17","unstructured":"IAS. 2023. High Prevalence of Latent Tuberculosis Infection among People Living with HIV in Thailand. https:\/\/programme.ias2023.org\/Abstract\/Abstract\/?abstractid=1987. Accessed\u00a05 Oct 2024."},{"key":"25491_CR18","unstructured":"World Health Organization. Tuberculosis profile: Thailand. https:\/\/worldhealthorg.shinyapps.io\/tb_profiles\/?_inputs_&entity_type=%22country%22&iso2=%22TH%22&lan=%22EN%22. Accessed 16 Sept 2024."},{"issue":"7","key":"25491_CR19","doi-asserted-by":"publisher","first-page":"e320","DOI":"10.1016\/S2666-5247(21)00044-6","volume":"2","author":"K Zurcher","year":"2021","unstructured":"Zurcher K, Reichmuth ML, Ballif M, Loiseau C, Borrell S, Reinhard M, et al. Mortality from drug-resistant tuberculosis in high-burden countries comparing routine drug susceptibility testing with whole-genome sequencing: a multicentre cohort study. Lancet Microbe. 2021;2(7):e320\u201330.","journal-title":"Lancet Microbe"},{"key":"25491_CR20","unstructured":"UNITAID. Evidence for 3HP. https:\/\/www.impaact4tb.org\/wp-content\/uploads\/2020\/04\/4T-eng-Evidence-for-3HP-technical-brief_RB17.pdf. Accessed 5 Oct 2024."},{"issue":"3","key":"25491_CR21","first-page":"270","volume":"9","author":"N Hiransuthikul","year":"2005","unstructured":"Hiransuthikul N, Nelson KE, Hiransuthikul P, Vorayingyong A, Paewplot R. INH preventive therapy among adult HIV-infected patients in Thailand. Int J Tuberc Lung Dis. 2005;9(3):270\u20135.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"2","key":"25491_CR22","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1097\/QAI.0000000000002842","volume":"89","author":"SM Nanyonga","year":"2022","unstructured":"Nanyonga SM, Kitutu FE, Kalyango J, Frank M, Kiguba R. High burden of adverse drug reactions to Isoniazid preventive therapy in people living with HIV at 3 tertiary hospitals in Uganda: associated factors. J Acquir Immune Defic Syndr. 2022;89(2):215\u201321.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"12","key":"25491_CR23","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1038\/s41591-020-1076-0","volume":"26","author":"RK Gupta","year":"2020","unstructured":"Gupta RK, Calderwood CJ, Yavlinsky A, Krutikov M, Quartagno M, Aichelburg MC, et al. Discovery and validation of a personalized risk predictor for incident tuberculosis in low transmission settings. Nat Med. 2020;26(12):1941\u20139.","journal-title":"Nat Med"},{"key":"25491_CR24","unstructured":"Trading Economics. Thailand - Immunization, BCG (% Of One-year-old Children) \u2013\u20092024 Data 2025 Forecast 1980\u20132022 Historical. https:\/\/tradingeconomics.com\/thailand\/immunization-bcg-percent-of-one-year-old-children-wb-data.html. Accessed 16 Sept 2024."},{"issue":"3","key":"25491_CR25","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1023\/B:QURE.0000021320.89524.64","volume":"13","author":"MJ Dion","year":"2004","unstructured":"Dion MJ, Tousignant P, Bourbeau J, Menzies D, Schwartzman K. Feasibility and reliability of health-related quality of life measurements among tuberculosis patients. Qual Life Res. 2004;13(3):653\u201365.","journal-title":"Qual Life Res"},{"key":"25491_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7525-7-14","volume":"7","author":"N Guo","year":"2009","unstructured":"Guo N, Marra F, Marra CA. Measuring health-related quality of life in tuberculosis: a systematic review. Health Qual Life Outcomes. 2009;7:14.","journal-title":"Health Qual Life Outcomes"},{"key":"25491_CR27","unstructured":"Human Life-Table Database (HLD). Thailand. https:\/\/www.lifetable.de\/Country\/Country?cntr=THA. Accessed 11 Sep 2025."},{"issue":"10","key":"25491_CR28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0274944","volume":"17","author":"W Isaranuwatchai","year":"2022","unstructured":"Isaranuwatchai W, Nakamura R, Wee HL, Sarajan MH, Wang Y, Soboon B, et al. What are the impacts of increasing cost-effectiveness threshold? A protocol on an empirical study based on economic evaluations conducted in Thailand. PLoS One. 2022;17(10):e0274944.","journal-title":"PLoS One"},{"key":"25491_CR29","volume":"18","author":"V Bhatia","year":"2023","unstructured":"Bhatia V, Rijal S, Sharma M, Islam A, Vassall A, Bhargava A, et al. Ending TB in South-East asia: flagship priority and response transformation. Lancet Reg Health. 2023;18:100301.","journal-title":"Lancet Reg Health"},{"issue":"1","key":"25491_CR30","doi-asserted-by":"publisher","DOI":"10.1080\/16549716.2018.1477493","volume":"11","author":"T Prasanna","year":"2018","unstructured":"Prasanna T, Jeyashree K, Chinnakali P, Bahurupi Y, Vasudevan K, Das M. Catastrophic costs of tuberculosis care: a mixed methods study from Puducherry, India. Glob Health Action. 2018;11(1):1477493.","journal-title":"Glob Health Action"},{"issue":"1","key":"25491_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s12890-022-02149-x","volume":"22","author":"J Mahon","year":"2022","unstructured":"Mahon J, Beale S, Holmes H, Arber M, Nikolayevskyy V, Alagna R, et al. A systematic review of cost-utility analyses of screening methods in latent tuberculosis infection in high-risk populations. BMC Pulm Med. 2022;22(1):375.","journal-title":"BMC Pulm Med"},{"key":"25491_CR32","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.vhri.2023.11.010","volume":"41","author":"CE Navarro","year":"2024","unstructured":"Navarro CE, Betancur JE. Cost-effectiveness analysis comparing QuantiFERON-TB gold plus test and tuberculin skin test for the diagnosis of latent tuberculosis infection in immunocompetent subjects in Colombia. Value Health Reg Issues. 2024;41:54\u201362.","journal-title":"Value Health Reg Issues"},{"issue":"1","key":"25491_CR33","doi-asserted-by":"publisher","first-page":"20","DOI":"10.5588\/ijtldopen.23.0342","volume":"1","author":"RK N\u2019Guessan","year":"2024","unstructured":"N\u2019Guessan RK, Orsot DAB, Ahui Brou JM, Bamba NK, Tchoutedjem Mefo ME, Bakayoko AS. Screening of household contacts for TB infection in Cote d\u2019Ivoire. IJTLD Open. 2024;1(1):20\u20136.","journal-title":"IJTLD Open"},{"issue":"1","key":"25491_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-22721-z","volume":"12","author":"G Fekadu","year":"2022","unstructured":"Fekadu G, Yao J, You JHS. Cost effectiveness analysis of single and sequential testing strategies for tuberculosis infection in adults living with HIV in the united States. Sci Rep. 2022;12(1):18349.","journal-title":"Sci Rep"},{"issue":"2","key":"25491_CR35","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.cmi.2024.09.012","volume":"31","author":"I Kontsevaya","year":"2025","unstructured":"Kontsevaya I. Revisiting diagnostics: a comprehensive approach to assessment of the tuberculosis infection screening strategy cost-effectiveness. Clin Microbiol Infect. 2025;31(2):144\u20136.","journal-title":"Clin Microbiol Infect"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-025-25491-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-025-25491-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-025-25491-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T14:51:16Z","timestamp":1764687076000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-025-25491-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,2]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["25491"],"URL":"https:\/\/doi.org\/10.1186\/s12889-025-25491-1","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,2]]},"assertion":[{"value":"10 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was a modelling study with all data inputs obtained from publicly available resources. Since no patient data were used, hence, ethical approval was not required. However, we adhered to the ethical standards of research integrity and transparency throughout our analysis and reporting process.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4207"}}